Your browser doesn't support javascript.
loading
Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-ß1/Smad2/3 signaling pathway based on network pharmacology analysis.
Wen, Ying; Zhang, Xiuli; Wei, Lihui; Wu, Meizhu; Cheng, Ying; Zheng, Huifang; Shen, Aling; Fu, Changgeng; Ali, Farman; Long, Linzi; Lu, Yao; Li, Jiapeng; Peng, Jun.
Afiliação
  • Wen Y; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Zhang X; Fujian Key Laboratory of Integrative Medicine in Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Wei L; Fujian Collaborative Innovation Center for Integrative Medicine in Prevention and Treatment of Major Chronic Cardiovascular Diseases, Fuzhou, China.
  • Wu M; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Cheng Y; Fujian Key Laboratory of Integrative Medicine in Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Zheng H; Fujian Collaborative Innovation Center for Integrative Medicine in Prevention and Treatment of Major Chronic Cardiovascular Diseases, Fuzhou, China.
  • Shen A; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Fu C; Fujian Key Laboratory of Integrative Medicine in Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Ali F; Fujian Collaborative Innovation Center for Integrative Medicine in Prevention and Treatment of Major Chronic Cardiovascular Diseases, Fuzhou, China.
  • Long L; Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Lu Y; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Li J; Fujian Key Laboratory of Integrative Medicine in Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Peng J; Fujian Collaborative Innovation Center for Integrative Medicine in Prevention and Treatment of Major Chronic Cardiovascular Diseases, Fuzhou, China.
Front Pharmacol ; 14: 1082281, 2023.
Article em En | MEDLINE | ID: mdl-36733505

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China